🔗 Permalink

Inventor profile of:

John Colucci

City:

Kirkland

Country:

Canada

Published Applications:

Last publication date:

2022-05-12

Top Assignees for applications by John Colucci

The entities that hold a legal rights for patent applications filed by inventor Colucci John:

Merck Canada Inc. 3 Quebec, Canada
Kaneq Pharma Inc. 3 Boucherville, Canada
AEROMICS, INC. 2 New Haven, CT United States
Debiopharm International SA 2 Lausanne, Switzerland
Aeromics, Inc. 2 Cleveland, OH United States
Merck Sharp Dohme Corp. 2 Rahway, NJ United States
Merck Frosst Canada Ltd. 1 Kirkland, Quebec, Canada
Merck & Co., Inc. 1 Rahway, NJ United States
Affinium Pharmaceuticals, Inc. 1 Toronto, Canada
Merck Frosst Canada 1 Kirkland, Canada
Merck Frosst Canada Ltd. 1 Kirkland, Province of Quebec, Canada
Kaneq Pharma Inc. 1 Boucherville, Quebec, Canada
Merck Canada Inc. 1 Kirkland, Quebec, Canada
Merck Frosst Canada Ltd. 1 Quebec, Canada
MERCK FROSST CANADA LTD. 1 Kirkland, QC Canada

Recent patent applications by Colucci John

John Colucci from Kirkland, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-05-12

US20220143048A1

Human necessities

Prodrug salts

#2 | 2020-09-24

US20200297740A1

Human necessities

Prodrug salts

#3 | 2018-06-21

US20180169118A1

Human necessities

Prodrug salts

#4 | 2016-09-15

US20160264604A1

Chemistry; metallurgy

Prodrug salts

#5 | 2015-03-05

US20150065415A1

Chemistry; metallurgy

Prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide

#6 | 2015-02-12

US20150045325A1

Chemistry; metallurgy

Fused aromatic PTP-1B inhibitors

#7 | 2014-02-20

US20140051666A1

Chemistry; metallurgy

Prodrug derivatives of (E)-N-methyl-N-((3-M ethylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide

#8 | 2013-10-24

US20130281365A1

Chemistry; metallurgy

Fused aromatic PTP-1B inhibitors

#9 | 2013-06-13

US20130150398A1

Chemistry; metallurgy

Indole derivatives as CRTH2 receptor antagonists

#10 | 2012-07-12

US20120178679A1

Chemistry; metallurgy

Fused aromatic PTP-1B inhibitors

#11 | 2011-09-29

US20110237511A1

Chemistry; metallurgy

EP4 Receptor Agonist, Compositions and Methods Thereof

#12 | 2011-07-14

US20110172263A1

Chemistry; metallurgy

Indole derivatives as CRTH2 receptor antagonists

#13 | 2010-09-16

US20100234415A1

Chemistry; metallurgy

Indole derivatives as CRTH2 receptor antagonists

#14 | 2010-01-28

US20100022477A1

Chemistry; metallurgy

Fused aromatic PTP-1B inhibitors

#15 | 2009-12-24

US20090318518A1

Chemistry; metallurgy

Indole and indoline cyclopropyl amide derivatives as EP4 receptor antagonists

#16 | 2009-10-29

US20090270395A1

Chemistry; metallurgy

EP4 Receptor Agonist, Compositions and Methods Thereof

#17 | 2009-10-08

US20090253756A1

Chemistry; metallurgy

Indole amide derivatives as EP4 receptor antagonists

#18 | 2009-04-23

US20090105321A1

Chemistry; metallurgy

Indoline amide derivatives as EP4 receptor ligands

#19 | 2009-04-23

US20090105234A1

Chemistry; metallurgy

EP4 Receptor Agonist, Compositions and Methods Thereof

#20 | 2009-04-16

US20090099226A1

Chemistry; metallurgy

Quinoline derivatives as EP4 antagonists

#21 | 2006-07-27

US20060167081A1

Chemistry; metallurgy

Ep4 receptor agonists

#22 | 2006-05-30

US10797257

EP receptor agonist, compositions and methods thereof

#23 | 2005-10-13

US20050227969A1

Chemistry; metallurgy

EPreceptor agonist, compositions and methods thereof

InventorID:

287947 ⎘